ArticleBehavioural neurology2026
Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom.
Article in Behavioural neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding Routine Treatment and Resource Availability for Fatigue in Multiple Sclerosis in the United Kingdom.Behavioural neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundFifty-five to ninety percent of people with multiple sclerosis (MS) report disabling fatigue, but a previous survey found that only 31% of UK adults with MS experiencing fatigue report being offered any treatment. The aim of this study was to capture the service perspective of routine care for MS fatigue and resource availability.
methodsA cross-sectional online survey was distributed to NHS services across the United Kingdom to be completed by healthcare professionals working with people with MS.
resultsEighteen services completed the survey. Services supported a median of 1100 patients. Allied healthcare professional availability varied across services but was generally low (median range 0-6 staff per type). On average, services estimated that only 28% (SD = 26.51) of patients were receiving fatigue treatments.
conclusionsFindings highlighted the unmet need around MS fatigue management, complementing previously captured patient perspectives. Although the study included a small, self-selecting subset of services and may have been influenced by the COVID-19 pandemic, it demonstrates the necessity of accounting for resource availability to successfully implement new fatigue interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.